                         SEQUENCE LISTING

<110>  Luo, Minkui
       Zheng, Weihong
 
<120>  Methyltransferase Inhibitors for Treating Cancer

<130>  3314.032AWO

<150>  US 61/812,393
<151>  2013-04-16

<160>  7     

<170>  PatentIn version 3.5

<210>  1
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide

<400>  1

Ala Arg Thr Lys Gln Thr Ala Arg Lys Ser Thr Gly Gly Lys Ala Pro 
1               5                   10                  15      


Arg Lys Gln Leu Ala 
            20      


<210>  2
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide

<400>  2

Gly Gly Arg Gly Gly Phe Gly Gly Arg Gly Gly Phe Gly Gly Arg Gly 
1               5                   10                  15      


Gly Phe Gly 
            


<210>  3
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide

<400>  3

Ala Arg Thr Lys Gln Thr Ala Arg Lys Ser Thr Gly Gly Lys Ala Pro 
1               5                   10                  15      


Arg Lys Gln Leu Ala Thr Lys Ala Ala Arg Lys Ser Ala Pro Ala Thr 
            20                  25                  30          


Gly Gly Val Lys Lys Pro His Arg 
        35                  40  


<210>  4
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide

<400>  4

Leu Gly Lys Gly Gly Ala Lys Arg His Arg Lys Val Leu Arg Asp Asn 
1               5                   10                  15      


Ile Gln Gly Ile Thr 
            20      


<210>  5
<211>  30
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide

<400>  5

Ala Thr Lys Ala Ala Arg Lys Ser Ala Pro Ala Thr Gly Gly Val Lys 
1               5                   10                  15      


Lys Pro His Arg Tyr Arg Pro Gly Thr Val Ala Leu Arg Glu 
            20                  25                  30  


<210>  6
<211>  34
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide

<400>  6

Gly Gly Ser Arg Ala His Ser Ser His Leu Lys Ser Lys Lys Gly Gln 
1               5                   10                  15      


Ser Thr Ser Arg His Lys Lys Leu Met Phe Lys Thr Glu Gly Pro Asp 
            20                  25                  30          


Ser Asp 
        


<210>  7
<211>  350
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide

<400>  7

Met Asp Asp Gln Gln Ala Leu Asn Ser Ile Met Gln Asp Leu Ala Val 
1               5                   10                  15      


Leu His Lys Ala Ser Arg Pro Ala Leu Ser Leu Gln Glu Thr Arg Lys 
            20                  25                  30          


Ala Lys Ser Ser Ser Pro Lys Lys Gln Asn Asp Val Arg Val Lys Phe 
        35                  40                  45              


Glu His Arg Gly Glu Lys Arg Ile Leu Gln Phe Pro Arg Pro Val Lys 
    50                  55                  60                  


Leu Glu Asp Leu Arg Ser Lys Ala Lys Ile Ala Phe Gly Gln Ser Met 
65                  70                  75                  80  


Asp Leu His Tyr Thr Asn Asn Glu Leu Val Ile Pro Leu Thr Thr Gln 
                85                  90                  95      


Asp Asp Leu Asp Lys Ala Val Glu Leu Leu Asp Arg Ser Ile His Met 
            100                 105                 110         


Lys Ser Leu Lys Ile Leu Leu Val Ile Asn Gly Ser Thr Gln Ala Thr 
        115                 120                 125             


Asn Leu Glu Pro Leu Pro Ser Leu Glu Asp Leu Asp Asn Thr Val Phe 
    130                 135                 140                 


Gly Ala Glu Arg Lys Lys Arg Leu Ser Ile Ile Gly Pro Thr Ser Arg 
145                 150                 155                 160 


Asp Arg Ser Ser Pro Pro Pro Gly Tyr Ile Pro Asp Glu Leu His Gln 
                165                 170                 175     


Val Ala Arg Asn Gly Ser Phe Thr Ser Ile Asn Ser Glu Gly Glu Phe 
            180                 185                 190         


Ile Pro Glu Ser Met Asp Gln Met Leu Asp Pro Leu Ser Leu Ser Ser 
        195                 200                 205             


Pro Glu Asn Ser Gly Ser Gly Ser Cys Pro Ser Leu Asp Ser Pro Leu 
    210                 215                 220                 


Asp Gly Glu Ser Tyr Pro Lys Ser Arg Met Pro Arg Ala Gln Ser Tyr 
225                 230                 235                 240 


Pro Asp Asn His Gln Glu Phe Ser Asp Tyr Asp Asn Pro Ile Phe Glu 
                245                 250                 255     


Lys Phe Gly Lys Gly Gly Thr Tyr Pro Arg Arg Tyr His Val Ser Tyr 
            260                 265                 270         


His His Gln Glu Tyr Asn Asp Gly Arg Lys Thr Phe Pro Arg Ala Arg 
        275                 280                 285             


Arg Thr Gln Gly Thr Ser Leu Arg Ser Pro Val Ser Phe Ser Pro Thr 
    290                 295                 300                 


Asp His Ser Leu Ser Thr Ser Ser Gly Ser Ser Ile Phe Thr Pro Glu 
305                 310                 315                 320 


Tyr Asp Asp Ser Arg Ile Arg Arg Arg Gly Ser Asp Ile Asp Asn Pro 
                325                 330                 335     


Thr Leu Thr Val Met Asp Ile Ser Pro Pro Ser Arg Ser Pro 
            340                 345                 350 


